Benztropine Can Cause Drowsiness and Sedation
Yes, benztropine can cause increased drowsiness, though this is not its most prominent side effect. The FDA drug label explicitly warns that benztropine "may impair mental and/or physical abilities required for performance of hazardous tasks, such as operating machinery or driving a motor vehicle" 1.
Mechanism and Clinical Context
Benztropine is an anticholinergic agent with structural features similar to atropine 1. While drowsiness is not listed as a primary adverse effect in the FDA labeling, the drug's anticholinergic properties can contribute to sedation, particularly when:
- Combined with other CNS depressants: The drug's central nervous system effects can be additive with other sedating medications
- Used in higher doses: Large doses may cause "weakness and inability to move particular muscle groups" 1, which patients may experience as fatigue or sedation
- Used in elderly or susceptible patients: Mental confusion and CNS depression are more likely in these populations 1
Important Clinical Considerations
Cognitive Effects vs. Sedation
The more prominent concern with benztropine is cognitive impairment rather than frank drowsiness. Research demonstrates that benztropine 4 mg/day significantly impairs:
Avoid using benztropine in elderly patients with dementia or cognitive impairment, as anticholinergic agents like benztropine are listed on the American Geriatrics Society Beers Criteria as potentially inappropriate medications in older adults 3.
Paradoxical CNS Effects
Benztropine can produce both CNS depression and stimulation 1. In overdose situations, CNS depression may be "preceded or followed by stimulation" 1, making the sedation profile unpredictable.
Drug Interactions Increasing Sedation Risk
When benztropine is combined with:
- SSRIs and neuroleptics: Increased risk of delirium rather than simple drowsiness 4
- Other anticholinergic medications: Additive CNS effects including potential sedation
- Lithium, chlorpromazine, and triazolam: Can trigger abnormal sleep phenomena including somnambulism 5
Practical Management
If drowsiness occurs with benztropine:
- Reduce the dose - Small dose adjustments often eliminate minor side effects 6
- Consider discontinuation if sedation impairs function, especially in elderly patients
- Limit prophylactic use to 7 days maximum when used for antipsychotic-induced dystonia prevention 7
- Monitor for more serious anticholinergic toxicity: confusion, delirium, visual hallucinations 1
The bottom line: While benztropine can cause drowsiness, its anticholinergic cognitive effects and potential for delirium are more clinically significant concerns, particularly in vulnerable populations.